At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis.
作者信息
Combe Christian, Kirsch Alexander H, Alfano Gaetano, Luyckx Valerie A, Shroff Rukshana, Kanbay Mehmet, van der Sande Frank, Basile Carlo
机构信息
Service de Néphrologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Unité INSERM 1026 BioTis, Université de Bordeaux, Bordeaux, France.
出版信息
Nephrol Dial Transplant. 2021 Mar 29;36(4):571-574. doi: 10.1093/ndt/gfab007.
Abstract
摘要
相似文献
1
At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis.至少有156个理由让接受中心血液透析的患者优先接种新冠疫苗。
Nephrol Dial Transplant. 2021 Mar 29;36(4):571-574. doi: 10.1093/ndt/gfab007.
2
Active immunization against hepatitis B infection of a haemodialysis population.
Natl Med J India. 1994 May-Jun;7(3):115-6.
3
Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.附录：透析中心指南：门诊血液透析中心与参考医院之间关系的建议。来自门诊透析组的意见。
Nefrologia. 2011;31(6):664-9. doi: 10.3265/Nefrologia.pre2011.Oct.11001.
4
The anticipated and the lived experience of home and in-centre haemodialysis: Is there a disconnect?家庭血液透析和中心血液透析的预期与实际体验：是否存在脱节？
J Health Psychol. 2017 Oct;22(12):1524-1533. doi: 10.1177/1359105316630135. Epub 2016 Mar 8.
5
Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?血液透析中心的新冠病毒疫苗接种：出血并发症的风险有哪些？
Clin Kidney J. 2021 Apr 1;14(6):1701-1703. doi: 10.1093/ckj/sfab059. eCollection 2021 Jun.
6
Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis.SHAREHD的基本原理与设计：一项质量改进合作项目，旨在扩大为接受中心血液透析的患者提供的共享血液透析护理服务。
BMC Nephrol. 2017 Nov 24;18(1):335. doi: 10.1186/s12882-017-0748-6.
7
Retrospective observational study examining indications for hospitalisation among haemodialysis patients at one of the Ministry of Health Hospitals in Makkah, Saudi Arabia.一项回顾性观察研究，调查沙特阿拉伯麦加市一家卫生部医院血液透析患者的住院指征。
JRSM Open. 2014 Oct 8;5(10):2054270414547146. doi: 10.1177/2054270414547146. eCollection 2014 Oct.
8
Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review.血液透析患者的乙肝疫苗接种：一个被低估的问题。意大利一家血液透析中心十年观察中影响免疫反应的因素及文献综述。
Ann Ig. 2017 Jan-Feb;29(1):27-37. doi: 10.7416/ai.2017.2129.
9
Efficacy of the accelerated hepatitis B vaccination schedule used in haemodialysis patients post-exposure to virus: a single-centre experience.
Nephrol Dial Transplant. 2002 Nov;17(11):1982-7. doi: 10.1093/ndt/17.11.1982.
10
Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients.原发性无反应血液透析患者皮内与肌内注射乙肝疫苗的比较
Nephrol Dial Transplant. 1996 Jan;11(1):191-3.
引用本文的文献
1
Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients.肾移植受者加强免疫接种后SARS-CoV-2免疫力的部分恢复。
Clin Immunol Commun. 2023 Dec;3:1-5. doi: 10.1016/j.clicom.2022.12.001. Epub 2022 Dec 11.
2
Clinical characteristics and outcomes of COVID-19 patients with varying renal functions statuses during the Omicron pandemic in Shanghai.奥密克戎疫情期间上海不同肾功能状态 COVID-19 患者的临床特征和转归。
BMC Nephrol. 2023 Aug 24;24(1):253. doi: 10.1186/s12882-023-03258-3.
3
Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients.血液透析患者接种mRNA-BNT162b2疫苗双剂后6个月体液免疫反应减弱
Acta Med Litu. 2023;30(1):26-38. doi: 10.15388/Amed.2023.30.1.3. Epub 2023 Jan 24.
4
Effect of Protective Measures Adopted in the COVID-19 Pandemic on Hemodialysis Patients.新冠疫情期间采取的防护措施对血液透析患者的影响。
Cureus. 2023 Feb 27;15(2):e35552. doi: 10.7759/cureus.35552. eCollection 2023 Feb.
5
Which criteria should we use to end isolation in hemodialysis patients with COVID-19?我们应该使用哪些标准来解除新冠肺炎血液透析患者的隔离？
Clin Kidney J. 2022 Apr 30;15(8):1450-1454. doi: 10.1093/ckj/sfac115. eCollection 2022 Aug.
6
Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology.在大流行高峰期，患有晚期慢性肾脏病和肾衰竭的患者中 COVID-19 疫苗的供应和优先排序：国际肾脏病学会的全球调查。
BMJ Open. 2022 Dec 30;12(12):e065112. doi: 10.1136/bmjopen-2022-065112.
7
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience.腹膜透析（PD）患者 COVID-19 的患病率、临床病程和结局：一项单中心经验。
Clin Exp Nephrol. 2023 Feb;27(2):171-178. doi: 10.1007/s10157-022-02283-0. Epub 2022 Nov 3.
8
The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease.肾病儿科患者面临的疫情挑战及新冠疫苗接种情况
J Bras Nefrol. 2023 Apr-Jun;45(2):244-251. doi: 10.1590/2175-8239-JBN-2022-0081en.
9
Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study.AZD1222新冠疫苗在透析患者中的抗体反应及不良事件：一项前瞻性队列研究
Vaccines (Basel). 2022 Sep 3;10(9):1460. doi: 10.3390/vaccines10091460.
10
Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?疫苗时代的新冠病毒肺炎肾替代治疗患者：我们需要了解什么？
Clin Kidney J. 2022 May 2;15(9):1639-1642. doi: 10.1093/ckj/sfac122. eCollection 2022 Sep.
Zotero 插件